C4 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. 

CEO
Andrew J. Hirsch
CEOAndrew J. Hirsch
Employees
110
Employees110
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
110
Employees110

CCCC Key Statistics

Market cap
99.76M
Market cap99.76M
Price-Earnings ratio
-0.93
Price-Earnings ratio-0.93
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$1.60
High today$1.60
Low today
$1.47
Low today$1.47
Open price
$1.59
Open price$1.59
Volume
23.57K
Volume23.57K
52 Week high
$7.66
52 Week high$7.66
52 Week low
$1.09
52 Week low$1.09

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own CCCC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.